Mark M Mitsnefes MD MS

PubMed

• 1 citations
  Investigation of a targeted panel of gut microbiome-derived toxins in children with chronic kidney disease.
  Mina Ebrahimi, Stephen R Hooper, Mark M Mitsnefes, Ramachandran S Vasan, Paul L Kimmel
  Pediatric Nephrology. 2025-05-01
• Interval healthcare provider contact and blood pressure control in children with chronic kidney disease and hypertension.
  John H Hammond, Derek K Ng, Eliza D Blanchette, Joseph T Flynn, Mark M Mitsnefes
  Pediatric Nephrology. 2025-03-24
• Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study.
  Gilad Hamdani, Elaine M Urbina, Stephen R Daniels, Bonita E Falkner, Michael A Ferguson
  Hypertension. 2025-02-27

Journal Articles

• Childhood Obesity and the Metabolic Syndrome  
  Edward Nehus, Mark Mitsnefes, ScienceDirect
• Coronary artery calcification and cardiovascular disease in children with chronic kidney disease  
  Paoli S, Mitsnefes MM, Curr Opin Pediatr, 1/1/2014
• Blood Pressure Control and Left Ventricular Hypertrophy Regression in Children with Chronic Kidney Disease  
  Kupferman J, Aronson Friedman L, Cox C, Flynn J, Furth S, Warady B, Mitsnefes MM, J Am Soc Nephrol, 1/1/2014
• Proteinuria is a Major Factor in Uncontrolled BP in Pediatric CKD  
  Kogon AJ, Pierce CB, Cox C, Brady TM, Mitsnefes MM, Warady BA, Furth SL, and Flynn JT, Kidney International, 1/1/2014
• Ceramides and cardiac function in children with chronic kidney disease  
  Mitsnefes MM, Scherer PE, Friedman LA, Gordillo R, Furth A, Warady BA; for the CKiD study group, Ped. Nephrol, 1/1/2014
• Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease  
  Omoloja A, Jerry-Fluker J, Ng DK, Abraham AG, Furth S, Warady BA, Mitsnefes MM, Pediatr Nephrol, 1/1/2013
• The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study  
  Hooper DK, Williams JC, Carle AC, Amaral S, Chand DH, Ferris ME, Patel HP, Licht C, Barletta GM, Zitterman V, Mitsnefes M, Patel UD, Pediatric Nephrology, 1/1/2013
• Ambulatory Arterial Stiffness Index (AASI): is there an additional value to characterize cardiovascular risk in children with kidney transplant?  
  Mitsnefes MM, Pediatric Transplantation, 1/1/2013
• Carotid Intima Media Thickness in Children with Chronic Kidney Disease: Results from the CKiD study  
  Brady TM, Schneider MF, Flynn, JT, Cox C, Samuels J, Saland J, White C, Furth S, Warady BA, Mitsnefes M, CJASN, 12/1/2012
• NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome  
  Bennett MR, Piyaphanee N, Czech K, Mitsnefes M, Devarajan P, Pediatr Nephrol, 5/1/2012
• Cardiovascular disease in children with chronic kidney disease  
  Mitsnefes MM, J Am Soc Nephrol, 4/1/2012
• Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease  
  Flynn JT, Pierce CB, Miller ER 3rd, Charleston J, Samuels JA, Kupferman J, Furth SL, Warady BA; Chronic Kidney Disease in Children Study Group, J Pediatr, 3/1/2012
• Adiponectin, Cardiovascular Disease, Chronic Kidney Disease: Emerging Data on Complex Interactions  
  Lo M, Mitsnefes MM, Pediatric Nephrology, 1/1/2012
• Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant  
  Malatesta-Muncher R, Wansapura J, Taylor M, Lindquist D, Hor K, Mitsnefes MM, Pediatric Nephrology, 1/1/2012
• Ambulatory Blood Pressure Patterns in Children With Chronic Kidney Disease  
  Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA, Furth S; for the Chronic Kidney Disease in Children Study Group, Hypertension, 1/1/2012
• Correlates of Resistin in Children with Chronic Kidney Disease: The Chronic Kidney Disease in Children Cohort  
  Nehus E, Furth S, Warady B, Mitsnefes M, J Pediatr, 1/1/2012
• Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?  
  Shroff R, Quinlan C, and Mitsnefes M, Pediatric Nephrology, 1/1/2011
• Frequent vs standard hemodialysis  
  Laskin B, Mitsnefes MM, N Engl J Med, 1/1/2011
• Discovery and initial validation of alpha 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome  
  Piyaphanee N, Ma Q, Kremen O, Czech K, Greis K, Mitsnefes M, Devarajan P, Bennett MR, Proteomics Clin Appl., 1/1/2011
• Cardiovascular disease in children with chronic kidney disease  
  Shroff R, Weaver J, and Mitsnefes MM, Nature review nephrology, 1/1/2011
• Hypertension in CKD  
  VanDeVoorde R, Mitsnefes MM, Advances in chronic kidney disease, 1/1/2011
• Dyslipidemia in Children with Chronic Kidney Disease: A Report of The Chronic Kidney Disease in Children (CKiD) Study  
  Saland J, Pierce C, Mitsnefes M, Flynn J, Goebel J, Kupferman J, Warady B, Furth S, Kidney Int, 1/1/2010
• Masked hypertension and associated left ventricular hypertrophy in children with CKD  
  Mitsnefes MM, Flynn J, Cohn S, Samuels J, Blydt-Hansen T , Saland J, Kimball T, Furth S , Warady B for the CKiD Study Group, J Am Soc Nephrol, 1/1/2010
• High Prevalence of the Metabolic Syndrome and Associated Left Ventricular Hypertrophy in Pediatric Renal Transplant Recipients  
  Wilson AC, Greenbaum LA, Barletta GM, Chand D, Lin JJ, Patel HP, Mitsnefes MM, Pediatric Transplantation, 1/1/2010
• Secondary hypertension in overweight and stage 1 hypertensive children - A Midwest Pediatric Nephrology Consortium Rep  
  Kapur G, Ahmed M, Pan C, Mitsnefes MM, Chiang M, Mattoo TK, J Clinical Hypertension, 1/1/2010
• Join now to see all

Books/Book Chapters

• Pediatric Hypertension. 
  Chapter: Sequelae of Hypertension in Children and Adolescents. 
  Weaver DJ, Mitsnefes MMEditors: Portman, Ingelfinger and Flynn.Edition 2nd,2013
• Kidney and Urinary Tract Diseases in the Neonate. 
  Chapter: Neonatal Hypertension. 
  VandeVoorde R, Mitsnefes MMEditors: Kiessling, Chishti, Alam.2012
• Pediatric Dialysis 
  Chapter: Cardiovascular disease. 
  Shroff R, Wuel E, Mitsnefes MMEditors: Warady, Schaefer and Alexander.Edition 2nd,2010
• Pediatric Hypertension 
  Chapter: Sequelae of Hypertension in Children and Adolescents. 
  Weaver DJ, Mitsnefes MMEditors: Portman, Ingelfinger and Flynn.2009
• Clinician’s Manual in Pediatric Nephrology. 
  Chapter: Cardiovascular Disease. 
  Wilson A, Mitsnefes MMEditors: Chand and Valentini.2009
• Dialysis Therapy 
  Chapter: Prevention and treatment of cardiovascular complications in children. 
  Mitsnefes MMEditors: Nissenson and Fine.Edition 4th,2007
• Clinical Pediatric Nephrology 
  Chapter: Cardiovascular disease in pediatric chronic kidney disease. 
  Mitsnefes MM and QuerfeldEditors: Geary and Schaefer.2007
• Current Pediatric Therapy 
  Chapter: Systemic Hypertension (include the child at risk for cardiovascular disease). 
  Mitsnefes MMEditors: Burg, Ingelfinger, Polin and Gershon.2006
• Pediatric Clinics of North America 
  Chapter: Hypertension in Children. 
  Mitsnefes MM2006
• Textbook on Kidney Disease in Children and Adolescents 
  Chapter: Cardiovascular Disease in Patients with Kidney Disorders in Childhood and Adolescence. 
  R. Parekh, M Mitsnefes, S DanielsEditors: R. Hogg.2005
• Comprehensive Pediatrics 
  Chapter: Long-term management of hypertension in children. 
  Mitsnefes MMEditors: L Osborn, TG DeWitt, and LR First.2004
• Join now to see all

Lectures

• Management of CKD in Children 
  American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
• Clinical approach to obesity and hypertension in children. 
  Atlanta, GA - 1/1/2013
• Fructose and uric acid: the role of dietary sweeteners in the development of the disease. 
  Shanghai, China - 1/1/2013
• Traditional CV risk in children with mild to moderate CKD: lessons from the CKiD study. 
  Shanghai, China - 1/1/2013
• Cardiovascular disease in childhood onset CKD. 
  Washington, DC - 1/1/2013
• Adipokines and CV risk in CKD. 
  San Diego, CA - 1/1/2012
• Hypertension post kidney transplant. 
  Boston, MA - 1/1/2012
• Masked Hypertension in children with CKD. 
  Miami, FL - 1/1/2012
• Cardiovascular risks in CKiD study. 
  Washington, DC - 1/1/2012
• Pathophysiology of cardiovascular damage in metabolic syndrome. 
  Krakow, Poland - 1/1/2012
• Adiponectin and CVD in CKD. (Endocrinology Grand Round) 
  CCHMC - 1/1/2012
• Cardiovascular disease in children with CKD: hidden reality. 
  Syracuse, NY - 1/1/2011
• Biomarkers of CVD in CKD. 
  San Juan, Puerto Rico - 1/1/2011
• Blood pressure control in dialysis: cardiovascular outcomes. 
  Miami, FL - 1/1/2011
• Cardiovascular disease in children with CKD; combined grand round. 
  Stanford-UCSF, CA - 1/1/2010
• Adiponectin in Chronic Kidney Disease. 
  UT Southwestern, Dallas, TX - 1/1/2010
• Masked Hypertension in CKD. 
  Denver, CO - 1/1/2010
• Masked hypertension and cardiovascular disease in children and adults. 
  Orlando, FL - 1/1/2010
• Dyslipidemias and Kidney Disease. 
  Miami, FL - 1/1/2010
• Hypertension and CKD: Are we doing a Good Job? 
  Miami, FL - 1/1/2010
• CVD in children with CKD. 
  Mercy Children’s Hospital, Kansas City, MI - 1/1/2009
• The impact of fluid management on cardiac disease in children. 
  Vancouver, BC - 1/1/2009
• Left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. 
  Orlando, FL - 1/1/2009
• Ambulatory blood pressure monitoring in children (session Chair): Masked hypertension in children (speaker). 
  Baltimore, MD - 1/1/2009
• Premature atherosclerosis in children with nephrotic syndrome. 
  Miami, FL - 1/1/2009
• Join now to see all